BDRX
Biodexa Pharmaceuticals
$1.57
−$0.08 (−4.85%)Jul 27, 2026
Key metrics
The numbers that frame BDRX today
- Market cap
- $0.00
- P/E (TTM)
- -0.0
- ROIC
- -1,148.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.56
- 52wk High
- $59.40
Growth
Revenue and earnings trend for BDRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BDRX
Is Biodexa Pharmaceuticals a good buy?
No. Biodexa Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of BDRX?
Biodexa Pharmaceuticals's market capitalization is $0.00.
What is the P/E ratio for BDRX stock?
Biodexa Pharmaceuticals's current P/E ratio is -0.
What is the 52-week high for BDRX stock?
The 52-week high for Biodexa Pharmaceuticals is $59.40. The current close of $1.57 is 97.4% below that high.
What is the 52-week low for BDRX stock?
The 52-week low for Biodexa Pharmaceuticals is $1.56. The current close of $1.57 is 0.6% above that low.
Does BDRX stock pay dividends?
Biodexa Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BDRX?
Biodexa Pharmaceuticals's Debt / Equity ratio is 0.01.